Thanks GC. I think what I was expecting was news of how MDR was bridging the gap to usage of GP link, and how successful that has been. Providing the link is one thing, but uptake is a different matter.
I was expecting a ground swell of support for GP link, which would ultimately flow through to earnings and SP. I have seen growth on the back of acquisitions, but haven't seen disclosure (could have missed it???) around growth that has been specifically achieved via GP link. I would like to understand what the company has achieved via organic (uptake) vs inorganic (acquisition) growth.
Add to My Watchlist
What is My Watchlist?
